Ketamine is a short-acting anesthetic agent that was first reported more than 50 years ago. The use of this drug has evolved and sub-anesthetic doses of ketamine are now routinely used in the treatment of neuropathic pain and as an opioid-sparing approach to pain control. The use of low-dose ketamine in the treatment of depression, suicidal ideation, and PTSD is also rapidly gaining acceptance. The goals of this presentation are to examine the transition of ketamine from an anesthetic agent to a promising new drug in psychiatry and to explore other potential uses of the drug. In order to achieve these goals, the presentation is designed to answer the following questions:
- What are scientific paradigms and why are they important in clinical practice?
- What is the “Ketamine Paradigm” and does it work?
- Do we know how ketamine works in the clinical treatment of depression, PTSD, pain? Why should we care?
- Where is ketamine going in the treatment of CNS disorders?
Department of Psychiatry Grand Rounds: Ketamine in Psychiatry
Presenter: Irving Wainer, PhD
Adjunct Professor, Department of Anesthesiology
Cooper Medical School of Rowan University
Tuesday, January 31, 2017
11 a.m. to 12:30 p.m.
Dean’s Conference Room
E&R Building
Camden
The learner objectives for this activity are to improve diagnostic skills, increase knowledge of all psychiatric disorders, and discuss recent advances in all areas of psychiatry, psychopharmacology, psychotherapy, and evaluative techniques.
The intended audience for this activity includes psychiatrists and psychologists. Other healthcare professionals including physicians from other disciplines, residents, medical students, nurses, therapists, and social workers may also participate.
The Cooper Health System is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Cooper Health System takes responsibility for the content, quality, and scientific integrity of this CME activity.
The Cooper Health System designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM per session. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of one hour of a continuing medical education (CME) course recognized by the American Medical Association, the American Osteopathic Association, or the American Podiatric Medical Association is equal to one hour of continuing education for New Jersey nursing license renewal (New Jersey Board of Nursing 13:37-5.3).
All faculty participating in CME activities sponsored by The Cooper Health System are expected to disclose to the audience any real or apparent conflict of interest related to the content of their presentation. Full Disclosure Statements will remain on file in the Department of CME.
For more information or to be placed on the mailing list, please contact the CME Coordinator Viktoria Rile at 856.757.7853.